Robert Weissman is president of Public Citizen, a national nonprofit consumer advocacy organization. He is an expert on economics, health care, trade and globalization, intellectual property and regulatory policy, and issues related to financial accountability and corporate responsibility.
Assessing the G-20 Declaration
This contradictory document identifies financial institution failures and calls for new regulatory measures, and at the same time, salutes the free market and some of the institutions behind the financial and economic crisis.
How private jet travel is straining the system, warming the planet, and costing you money.
AIDS and Developing Countries: Facilitating Access to Essential Medicines
Compulsory licensing and parallel importing policies could help developing country governments make essential medicines more affordable to their citizens.
"Free Trade" and Medicines in the Americas
The U.S. is pushing a negotiating agenda for the FTAA that would dramatically limit each countrys ability to undertake compulsory licensing, an important tool to promote generic competition.
Global Public Health: Access to Essential Medicines
Former U.S. Surgeon General David Satcher has likened the HIV/AIDS epidemic in Africa to the plague that decimated Europe in the fourteenth century.
Sell the Gold, Free the Poor
When historians look back over the past 25 years, one of the great crimes they will identify is the Third World debt crisis.
AIDS and Developing Countries: Democratizing Access
U.S. Surgeon General David Satcher has likened the HIV/AIDS epidemic in Africa to the plague that decimated Europe in the fourteenth century.
International Tobacco Sales (revised Oct 2000)
The human costs of tobacco use are staggering and rising dramatically.